JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency

Clinical trial NCT06662188 · RECRUITING

Trial details

NCT number: NCT06662188
Sponsor: Jaguar Gene Therapy, LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SHANK3 Haploinsufficiency Phelan-McDermid Syndrome

Start date: 2024-01-07
Primary completion: 2028-06-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.